Mehmet Akce
0000-0003-4747-7722
Publication & Citation Trends
Most Cited Works
Publications
196 total
Olaparib in Patients With Solid Tumors With ATM Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Cited by 0
Semantic Scholar
A phase Ib/II, dose escalation and dose expansion study of valemetostat tosylate (DS-3201b) with atezolizumab and bevacizumab in advanced hepatocellular carcinoma (HCC).
Cited by 0
Semantic Scholar
Circulating Tumor DNA-Based Assessment of Minimal Residual Disease in Colorectal Cancer: Prognostic and Predictive Implications.
Cited by 0
Semantic Scholar
ADT-030, a novel PDE10 inhibitor, demonstrates potent antitumor activity in pancreatic ductal adenocarcinoma
Cited by 1
Semantic Scholar
Abstract 2739: Evaluation of large language models for automated clinical trial matching in oncology.
Cited by 0
Semantic Scholar
ProAgio, a Novel Integrin αvβ3 Targeted Cytotoxin, Suppresses Tumor Growth and Reprograms the PDAC Microenvironment
Cited by 0
Semantic Scholar
Impact of hepatic arterial infusion pump (HAIP) therapy on disease control and survival outcome in metastatic colorectal cancer patients.
Cited by 0
Semantic Scholar
Abstract 7088: NAD(P)H: Quinone oxidoreductase 1 (NQO1): Is it a potential molecular target in colorectal cancer
Cited by 0
Semantic Scholar
Research Topics
Pancreatic and Hepatic Oncology Research
(45)
Colorectal Cancer Treatments and Studies
(42)
Cancer Immunotherapy and Biomarkers
(32)
Hepatocellular Carcinoma Treatment and Prognosis
(27)
Cholangiocarcinoma and Gallbladder Cancer Studies
(25)
Frequent Co-Authors
Affiliations
Novartis (Switzerland)
Emory Healthcare
University of Alabama at Birmingham Hospital
Mercy Medical Center
Emory University